PSTX
Charles Schwab’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-589,007
| Closed | -$5.65M | – | 3544 |
|
|
2024
Q4 | $5.65M | Buy |
589,007
+21,944
| +4% | +$211K | ﹤0.01% | 2286 |
|
|
2024
Q3 | $1.62M | Buy |
567,063
+21,255
| +4% | +$60.8K | ﹤0.01% | 2767 |
|
|
2024
Q2 | $1.59M | Buy |
545,808
+13,215
| +2% | +$38.6K | ﹤0.01% | 2780 |
|
|
2024
Q1 | $1.7M | Buy |
532,593
+22,830
| +4% | +$72.8K | ﹤0.01% | 2641 |
|
|
2023
Q4 | $1.71M | Buy |
509,763
+6,687
| +1% | +$22.5K | ﹤0.01% | 2661 |
|
|
2023
Q3 | $1.2M | Buy |
503,076
+73,500
| +17% | +$175K | ﹤0.01% | 2744 |
|
|
2023
Q2 | $756K | Buy |
429,576
+168,830
| +65% | +$297K | ﹤0.01% | 2866 |
|
|
2023
Q1 | $803K | Sell |
260,746
-3,831
| -1% | -$11.8K | ﹤0.01% | 2813 |
|
|
2022
Q4 | $1.4M | Buy |
264,577
+5,286
| +2% | +$28K | ﹤0.01% | 2666 |
|
|
2022
Q3 | $916K | Buy |
259,291
+126,872
| +96% | +$448K | ﹤0.01% | 2815 |
|
|
2022
Q2 | $342K | Sell |
132,419
-87,671
| -40% | -$226K | ﹤0.01% | 3172 |
|
|
2022
Q1 | $987K | Buy |
220,090
+8,329
| +4% | +$37.4K | ﹤0.01% | 2851 |
|
|
2021
Q4 | $1.44M | Buy |
211,761
+2,826
| +1% | +$19.3K | ﹤0.01% | 2793 |
|
|
2021
Q3 | $1.52M | Buy |
208,935
+80,870
| +63% | +$590K | ﹤0.01% | 2757 |
|
|
2021
Q2 | $1.28M | Sell |
128,065
-13,451
| -10% | -$135K | ﹤0.01% | 2845 |
|
|
2021
Q1 | $1.35M | Buy |
141,516
+52,038
| +58% | +$497K | ﹤0.01% | 2757 |
|
|
2020
Q4 | $982K | Buy |
89,478
+1,500
| +2% | +$16.5K | ﹤0.01% | 2780 |
|
|
2020
Q3 | $781K | Buy |
+87,978
| New | +$781K | ﹤0.01% | 2732 |
|